SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Follow Compare Add to Portfolio 1Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 47199
 
 
 
C07K PEPTIDES 2599
 
 
 
C07D HETEROCYCLIC COMPOUNDS 15136
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 13140
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 8109
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8175
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 652
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 6122
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 487
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 395

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0022,831 Peptides that Selectively Home to Heart Vasculature and Related Conjugates and MethodsMar 22, 15Jan 28, 16[A61K, C07K]
2015/0353,603 ENDOMETRIOSIS CELL TARGETING PEPTIDE AND USES THEREOFApr 10, 15Dec 10, 15[G01N, A61K, C07K]
2015/0329,497 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1Dec 19, 13Nov 19, 15[C07D, A61K]
2015/0307,499 INHIBITOR OF APOPTOSIS PROTEIN (IAP) ANTAGONISTSNov 26, 13Oct 29, 15[C07D]
2015/0266,842 METHODS AND COMPOSITIONS RELATED TO A RETINOID RECEPTOR-SELECTIVE PATHWAYMay 06, 11Sep 24, 15[C07D, C07C]
2015/0266,964 METHODS FOR ACCELERATING IMMUNE REGENERATIONOct 04, 13Sep 24, 15[C07K]
2015/0259,380 Truncated LYP-1 Peptides and Methods and Compositions Using Truncated LYP-1 PeptidesAug 24, 12Sep 17, 15[A61K, C07K]
2015/0212,086 Diagnosis and Treatment of Brain TumorApr 25, 13Jul 30, 15[C12N, A61K, G01N, C07K]
2015/0203,477 COMPOUNDS AND METHODS FOR ACTIVATING THE APOPTOTIC ARM OF THE UNFOLDED PROTEIN RESPONSEJun 18, 13Jul 23, 15[C07D, C07C, A61K]
2015/0051,138 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASESMar 14, 13Feb 19, 15[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,320,810 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cellsOct 30, 13Apr 26, 16[A61K, C07K]
9,266,828 Inhibitors of Furin and other pro-protein convertasesMar 14, 13Feb 23, 16[A61P, C07C, A61K, C07K]
9,238,654 Singleton inhibitors of sumoylation enzymes and methods for their useMay 09, 13Jan 19, 16[C07D, A61K]
9,238,815 Compositions and methods for inhibiting human host factors required for influenza virus replicationDec 10, 10Jan 19, 16[C12N, A61K]
9,233,926 Compounds for stem cell differentiationMar 23, 12Jan 12, 16[C07D, A61K]
9,193,710 Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereofAug 29, 12Nov 24, 15[C07D, A61K]
9,180,161 CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disordersFeb 28, 11Nov 10, 15[A61K, C07K]
9,120,787 HIV replication inhibitorsAug 27, 12Sep 01, 15[C07D, A61K]
9,115,170 Methods and compositions related to internalizing RGD peptidesJan 30, 13Aug 25, 15[A61K, C07K]
9,101,671 Methods and compositions related to clot binding compoundsDec 31, 07Aug 11, 15[A61K, B82Y]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0243,387 METHODS FOR IMPROVING CARDIAC CONTRACTILITYABANDec 17, 13Aug 28, 14[C12N, G01N]
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USEABANSep 28, 11Aug 29, 13[C07K]
2013/0225,427 METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICSABANNov 07, 12Aug 29, 13[C12Q, G01N]
2013/0210,124 DETERMINATION OF CANCER PREDISPOSITIONABANFeb 08, 13Aug 15, 13[G06F]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEABANDec 10, 12Jul 18, 13[A61K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISABANDec 02, 10Jun 20, 13[G01N]
2013/0100,272 Multifunction autofocus system and method for automated microscopyABANOct 25, 11Apr 25, 13[H04N]
2013/0064,799 METHODS FOR PROMOTING CELL REPROGRAMMINGABANMay 31, 12Mar 14, 13[C12N, C40B, G01N, A61K]
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESABANFeb 28, 12Mar 07, 13[A61P, A61K, B82Y, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSABANOct 31, 11Nov 01, 12[C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0269,901 Methods and Compounds Useful to Induce Apoptosis in Cancer CellsABANDec 19, 11Oct 25, 12[A61P, G01N, A61K]
2012/0204,273 COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USEABANDec 22, 11Aug 09, 12[C12N, A01K, A61P, C12Q, G01N, A61K]
2012/0196,922 ZNF206: A NOVEL REGULATOR OF EMBRYONIC STEM CELL SELF-RENEWAL AND PLURIPOTENCYABANDec 05, 11Aug 02, 12[C12N, C07H, C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0190,615 METHODS AND COMPOSITIONS FOR INDUCING WEIGHT LOSSABANJan 18, 12Jul 26, 12[A61P, A61K]
2012/0094,922 SCREENING ASSAYS FOR AGENTS THAT ALTER INHIBITOR OF APOPTOSIS (IAP) PROTEIN REGULATION OF CASPASE ACTIVITYABANNov 02, 11Apr 19, 12[A61P, C12Q, G01N, A61K]
2012/0095,032 METHODS FOR TREATING LEUKEMIA AND MYELODYSPLASTIC SYNDROME, AND METHODS FOR IDENTIFYING AGENTS FOR TREATING SAMEABANDec 06, 11Apr 19, 12[C12N, A61P, A61K]
2012/0095,078 METHODS OF DIAGNOSIS AND TREATMENT OF MELANOMAABANOct 07, 11Apr 19, 12[C40B, A61P, C12Q, A61K]
2012/0088,678 METHOD FOR PREDICTION OF RESPONSE TO RHEUMATOID ARTHRITIS THERAPEUTICSABANSep 08, 11Apr 12, 12[C40B, C12Q, G01N]
2012/0088,771 TISSUE-NONSPECIFIC ALKALINE PHOSPHATASE (TNAP): A THERAPEUTIC TARGET FOR ARTERIAL CALCIFICATIONABANOct 11, 11Apr 12, 12[C07D, A61P, C07C, A61K]
2012/0071,629 APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCERABANJul 20, 11Mar 22, 12[C07H, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.